©The Author(s) 2021.
World J Transplant. Oct 18, 2021; 11(10): 432-442
Published online Oct 18, 2021. doi: 10.5500/wjt.v11.i10.432
Published online Oct 18, 2021. doi: 10.5500/wjt.v11.i10.432
Table 2 Most commonly reported predictors for developing post-transplant diabetes mellitus
| Predictor | n | Fraction |
| African-American | 59 | 27/59 |
| Age | 56 | 51/56 |
| BMI | 43 | 39/43 |
| Tac use | 31 | 24/31 |
| HCV | 20 | 15/20 |
| BPAR | 13 | 10/13 |
| Male | 11 | 4/11 |
| Family history of diabetes | 7 | 6/7 |
| Pre transplant triglycerides | 7 | 7/7 |
| Pre transplant impaired fasting glucose | 6 | 6/6 |
| CMV infection | 5 | 2/5 |
| Proteinuria at post-operative day 5 | 3 | 3/3 |
| Number of rejections | 3 | 2/3 |
| Triglyceride lipid increase | 2 | 2/2 |
| HLA mismatch | 2 | 0/2 |
| HBV | 1 | 1/1 |
| Non-Caucasian | 1 | 1/1 |
| Cystic fibrosis | 1 | 1/1 |
| Cadaveric donor | 1 | 1/1 |
- Citation: Kotha S, Lawendy B, Asim S, Gomes C, Yu J, Orchanian-Cheff A, Tomlinson G, Bhat M. Impact of immunosuppression on incidence of post-transplant diabetes mellitus in solid organ transplant recipients: Systematic review and meta-analysis. World J Transplant 2021; 11(10): 432-442
- URL: https://www.wjgnet.com/2220-3230/full/v11/i10/432.htm
- DOI: https://dx.doi.org/10.5500/wjt.v11.i10.432